The Internet journal of hematology最新文献

筛选

英文中文

The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant Outcomes. 干细胞移植前铁蛋白水平对移植晚期并发症的影响:铁超载对移植晚期预后的潜在作用分析

The Internet journal of hematology Pub Date : 2009-01-01 DOI: 10.5580/17d5

Y. Efebera, Rupinderjit S Thandi, R. Saliba, U. Popat, M. de Lima, A. Alousi, C. Hosing, G. Rondon, R. Champlin, S. Giralt

{"title":"The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant Outcomes.","authors":"Y. Efebera, Rupinderjit S Thandi, R. Saliba, U. Popat, M. de Lima, A. Alousi, C. Hosing, G. Rondon, R. Champlin, S. Giralt","doi":"10.5580/17d5","DOIUrl":"https://doi.org/10.5580/17d5","url":null,"abstract":"BACKGROUND Iron overload has been associated with increased non-relapse mortality (NRM) in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) undergoing hematopoietic stem cell transplantation (HSCT). Elevated ferritin level pre-HSCT has been used as a marker for iron overload. It is unclear whether the negative effect of iron overload as measured by elevated ferritin level extends beyond the first three months post HSCT, as this would suggest a potential role for active management of iron overload post HSCT. PATIENTS Sixty-three patients with AML and MDS who underwent an allogeneic HSCT from a sibling or unrelated donor between January to December 2006, had a pre-HSCT ferritin level and were alive and disease free 90 days post HSCT. RESULTS Median age was 51. Patients with the lowest pre-HSCT ferritin level (Q1) had a trend towards improved overall survival and progression free survival when compared to patients with higher level (Q2-Q4) (P=0.06, and 0.125). Cumulative incidence of NRM at 2 years was 20 and 30% respectively (P=0.4). CONCLUSION Pre-HSCT ferritin level may still have an impact on HSCT events beyond 3 months post transplant, suggesting a role for research into active management of iron overload with either phlebotomy or chelation.","PeriodicalId":90742,"journal":{"name":"The Internet journal of hematology","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70813893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

The Internet journal of hematology Pub Date : 2009-01-01

Yvonne A Efebera, Rupinderjit S Thandi, Rima M Saliba, Uday Popat, Marcos De Lima, Amin Alousi, Chitra Hosing, Gabriela Rondon, Richard Champlin, Sergio Giralt

{"title":"The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant Outcomes.","authors":"Yvonne A Efebera, Rupinderjit S Thandi, Rima M Saliba, Uday Popat, Marcos De Lima, Amin Alousi, Chitra Hosing, Gabriela Rondon, Richard Champlin, Sergio Giralt","doi":"","DOIUrl":"","url":null,"abstract":"Background: Iron overload has been associated with increased non-relapse mortality (NRM) in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) undergoing hematopoietic stem cell transplantation (HSCT). Elevated ferritin level pre-HSCT has been used as a marker for iron overload. It is unclear whether the negative effect of iron overload as measured by elevated ferritin level extends beyond the first three months post HSCT, as this would suggest a potential role for active management of iron overload post HSCT.Patients: Sixty-three patients with AML and MDS who underwent an allogeneic HSCT from a sibling or unrelated donor between January to December 2006, had a pre-HSCT ferritin level and were alive and disease free 90 days post HSCT.Results: Median age was 51. Patients with the lowest pre-HSCT ferritin level (Q1) had a trend towards improved overall survival and progression free survival when compared to patients with higher level (Q2-Q4) (P=0.06, and 0.125). Cumulative incidence of NRM at 2 years was 20 and 30% respectively (P=0.4).Conclusion: Pre-HSCT ferritin level may still have an impact on HSCT events beyond 3 months post transplant, suggesting a role for research into active management of iron overload with either phlebotomy or chelation.","PeriodicalId":90742,"journal":{"name":"The Internet journal of hematology","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209589/pdf/nihms385293.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32780016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0